Navigation Links
Protalex, Inc. Announces Screening Of First Patients In U.S. For New Trial Of PRTX-100 In Patients With Active Rheumatoid Arthritis
Date:11/8/2012

eating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex's lead product, PRTX-100, is formulated with a proprietary highly purified form of Staphylococcal Protein A, and has completed a Phase 1b clinical trial on adult patients with active rheumatoid arthritis in South Africa which demonstrated that PRTX-100 was generally safe and well tolerated at all dose level and at the higher doses, more patients showed improvement in their CDAI (Clinical Disease Activity Index for RA) than did patients at the lower dose or placebo cohorts. PRTX-100 has the ability, at very low concentrations, to bind to and to regulate activation of human B-lymphocytes and macrophages, which mediate inflammation in certain autoimmune diseases.  Laboratory studies indicate that the mechanism involves interaction with specific intracellular signaling pathways.

Forward-Looking Statements

Statements in this press release, including with respect to the outcome of the Phase 1b study described, that are not statements of historical or current fact constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's filings with Securities and Exchange Commission.

Media Contact:
Mackenzie Mills
SpecO
'/>"/>

SOURCE Protalex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
2. ActiveCare Announces Record Revenue For Quarter Ending June 30, 2012
3. Echo Therapeutics Announces Third Quarter 2012 Financial Results
4. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
5. Winner Medical Announces Mailing of Definitive Proxy Materials for Special Meeting of Shareholders
6. Genoa Pharmaceuticals announces $1.2M Financing
7. Genomic Health Announces Third Quarter 2012 Financial Results and Business Progress
8. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
9. Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
10. Blue Belt Technologies Announces First United Kingdom-Based NavioPFS Unicondylar Knee Replacement Surgery
11. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... DUBLIN , Oct. 24, 2014 ... "Dental Equipment Market Current Trends, Opportunities - Global ... In this report, the global dental equipment ... geography. The dental systems and equipment market is expected ... equipment market during the forecast period (2014 to 2019). ...
(Date:10/25/2014)... , October 24, 2014 ... announced the addition of the "Global and ... to their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... Industry Report 2014 is a professional and in-depth ... concentrates industry with a focus on the Chinese ...
(Date:10/25/2014)... , Oct. 24, 2014 In conjunction ... quarter 2014 financial results press release, you are invited ... broadcast live over the internet on Monday, November 3, ... Time). A live audio webcast of the ... http://www.durect.com and clicking "Investor Relations."  If you ...
Breaking Medicine Technology:Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Global and Chinese Hemodialysis Concentrates Industry Report 2014 2Global and Chinese Hemodialysis Concentrates Industry Report 2014 3DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2
...   Jubilant Biosys Ltd., Bengaluru, ... announced another,successful delivery of an early stage milestone in ... years ago in the Neuroscience,therapeutic area, has now expanded ... of a steady stream of,preclinical outcomes to AstraZeneca, by ...
... Cepheid (Nasdaq: CPHD ) today announced that ... Vice President of Infectious Disease Research and Development, reporting ... offers an impressive menu of eleven highly regarded Xpert® ... aggressively to extend our leadership with next-generation products, including ...
Cached Medicine Technology:Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery 2Cepheid Appoints Vice President of Infectious Disease Research & Development 2Cepheid Appoints Vice President of Infectious Disease Research & Development 3
(Date:10/25/2014)... THURSDAY, Oct. 23, 2014 (HealthDay News) -- A large ... West Africa is to avoid tens of thousands of ... Yale University researchers predict. Using a specially ... future of the outbreak in just one densely populated ... the capital city of Monrovia. The researchers said ...
(Date:10/25/2014)... News) -- October,s shorter, darker days can trigger a ... to an expert. People affected by seasonal ... lack motivation and even have trouble getting out of ... said Dr. Angelos Halaris, a professor in the department ... Stitch School of Medicine. "Seasonal affective disorder should ...
(Date:10/22/2014)... October 22, 2014 On October 22, ... featuring skin diseases both fictional and real. The ... a nonprofit organization committed to advocacy and philanthropy in ... will take the opportunity to impart truth and clarity ... , There are many misconceptions about Morgellons Disease ...
(Date:10/22/2014)... Va. (PRWEB) October 22, 2014 For Dr. ... to make money; it’s an extension of her life’s mission. ... latest venture as the owner of FirstLight HomeCare, make it ... “It’s important to me that my work makes a difference ... harbored an entrepreneurial spirit, so after much research, I felt ...
(Date:10/22/2014)... Shriners Hospitals for Children® and UK HealthCare ... location of Shriners Hospitals for Children - Lexington from ... University of Kentucky Albert B. Chandler Hospital. The new ... and operated by Shriners Hospitals for Children, and designed ... their families well into the future. , “The quality ...
Breaking Medicine News(10 mins):Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3
... MIAMI , Feb. 3 One of the nation,s ... Randy Miller , MD of The MIAMI Institute for Age Management ... Surgeons, one of the nation,s largest specialty societies. , Greater than ... United States practice in Florida . The Florida Society ...
... increased the vaccination rate among St. Louis-based BJC HealthCare,s ... to a report now online in the journal ... infectious disease specialist Hilary Babcock, M.D., says the success ... implement a vaccination campaign on a large scale in ...
... injure their feet on Wii boards, report notes , WEDNESDAY, ... to video gaming in 2006, more than just the ligaments ... these days: a new report details foot injuries that have ... these types of games were introduced, patients typically presented with ...
... ... the Children, in partnership with the World Food Program (WFP), successfully distributed critically needed ... people. , ... Port-Au-Prince, Haiti (Vocus) February 3, 2010 -- The global humanitarian organization Save the ...
... , CINCINNATI , Feb. 3 ... as the winningest in franchise history, with a first time trip to ... BREES ( PURDUE ) consistent and dependable blocking throughout the ... Orleans Saints offensive line was the first to be honored and named ...
... , Feb. 3 In ... John McCain (R-Ariz.), and the US Anti-Doping Agency, ... Natural Products Association (NPA), the oldest and largest trade association representing ... issued the following statement: , "Our industry has ...
Cached Medicine News:Health News:Dr. Randy Miller Is Named President-Elect of the Florida Society of Plastic Surgeons 2Health News:Dr. Randy Miller Is Named President-Elect of the Florida Society of Plastic Surgeons 3Health News: Flu vaccination rate at large, Midwest health system rises dramatically due to mandatory policy 2Health News: Flu vaccination rate at large, Midwest health system rises dramatically due to mandatory policy 3Health News:Wii Popularity Leads to New Kind of Gaming Injury 2Health News:Wii Popularity Leads to New Kind of Gaming Injury 3Health News:Save the Children Supplies 30,000 Haitian Children and Families with Rice at Sites in Marissant and Tabarre, Will Continue for Two Weeks 2Health News:Save the Children Supplies 30,000 Haitian Children and Families with Rice at Sites in Marissant and Tabarre, Will Continue for Two Weeks 3Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 2Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 3Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 4Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 5Health News:Natural Products Questions Potential Threat to Dietary Supplement Health and Education Act 2
MDI will work with your facility to determine the best interim lab to fit your needs and your site....
... layout is designed efficiently for maximum ... configured for maximum efficiency. It is ... It can be set-up in 15 ... mobile modality pad and it has ...
... is the largest and most experienced provider ... in the United States. Mobile laboratories serving ... daily basis, from one hospital to another ... area. Each mobile laboratory is fully equipped ...
... PowerSuite holmium laser combines excellent cutting, ... virtually bloodless procedures. It is also ... gall bladder stones of all compositions, ... tool. Because its laser light is ...
Medicine Products: